We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$473M
AUM Growth
-$74.8M
Cap. Flow
-$100M
Cap. Flow %
-21.13%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$128M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$1.1M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$189M

Sector Composition

Rank Sector Weight
1 Healthcare 55.7%
2 Consumer Staples 30.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$147M 31.08%
+1,630,968
New +$128M
MNST icon
2
Monster Beverage
MNST
$94.3B
$147M 30.98%
9,594,816
– –
STAA icon
3
STAAR Surgical
STAA
$1.21B
$73.2M 15.47%
6,887,095
– –
MNST icon
4
PUT
Monster Beverage
MNST
$94.3B
$45.8M 9.69%
3,000,000
-3,000,000
-50% -$39.4M
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$43.3M 9.15%
17,088,778
+458,434
+3% +$1.1M
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$17.2M 3.63%
817,029
– –
QCOR
7
DELISTED
QUESTCOR PHARMA INC
QCOR
– –
-2,046,660
Closed -$189M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Broadwood Capital held 7 positions worth $473M, down 14% from $548M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $100M in Q3 2014, closing 1 position and reducing 1 holding. Its most notable exit was QUESTCOR PHARMA INC, an estimated $189M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 29% a quarter earlier, followed by Consumer Staples.

Against the trend, Broadwood Capital opened a new position in MALLINCKRODT PUBLIC LIMITED COMPANY worth $147M.

  • Broadwood Capital's largest Q3 2014 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,630,968 shares worth $147M.
  • Broadwood Capital added most to Lineage Cell Therapeutics in Q3 2014, an estimated $1.1M increase.
  • Broadwood Capital fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $189M.
  • Broadwood Capital's ten largest holdings make up 100% of its $473M portfolio in Q3 2014.
  • Broadwood Capital opened 1 new position and closed 1 in Q3 2014.
  • Broadwood Capital's portfolio value fell 14% quarter-over-quarter to $473M.

Based on Broadwood Capital's 13F filing for Q3 2014, filed 14 Nov 2014.